About Us

State-of-the-Art Products

AlcoaOne's genetic screening services, for both PGx (Pharmacogenomics) and CGx (Cancer Genomics - Hereditary Cancer), are at the pinnacle of medical technology, offering precise, personalized, and comprehensive insights into an individual's unique genetic makeup. This new technology allows for personalized treatment strategies that optimize better health outcomes and minimize side effects.

Cutting-Edge Research and Development

Our team is committed to continuously advancing the field of pharmacogenomics and cancer genomics using next generation sequencing (NGS), MassArray, and OpenArray technologies. We prioritize investment in research and development, always at the forefront of scientific discovery, to ensure our PGx and CGx testing methods are accurate, efficient, and clinically relevant.

Adherence to Regulatory Standards

At AlcoaOne, we are fully compliant with all relevant regulatory standards for genetic testing. Our PGX and CGX tests undergo rigorous quality control (QC) to ensure they meet and exceed industry guidelines, providing you with the most reliable & trustworthy clinical data. Customer-Centric Approach We believe that every patient is unique and deserves a personalized approach. Our team’s commitment to our customers is reflected in our easily accessible genetic testing services for PGX and CGX. We strive to empower patients and healthcare providers with accurate genetic information, promoting informed decision-making and personalized healthcare solutions.

Our Commitment to Accessible Personalized Care

At AlcoaOne, our mission is to provide the most advanced diagnostic healthcare to all patients, aiming to enhance clinical outcomes and patient experiences. Our comprehensive, cost-free approach reflects our commitment to bridging the healthcare gap and provide accessibility to care.